FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

702836004: Trastuzumab emtansine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006212012 Trastuzumab emtansine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006214013 Trastuzumab emtansine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
847141000172118 trastuzumab emtansine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab emtansine Is a Trastuzumab (substance) false Inferred relationship Some
Trastuzumab emtansine This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Some
Trastuzumab emtansine This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Trastuzumab emtansine Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Trastuzumab emtansine Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Trastuzumab emtansine Is a Antineoplastic agent (substance) false Inferred relationship Some
Trastuzumab emtansine This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Trastuzumab (substance) false Inferred relationship Some
Trastuzumab emtansine Is a Enzyme inhibitor protein true Inferred relationship Some
Trastuzumab emtansine Is a Immunosuppressant (substance) true Inferred relationship Some
Trastuzumab emtansine Is a Monoclonal antibody true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab emtansine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab emtansine Inferred relationship Some 1
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 100 mg powder for solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Trastuzumab emtansine Inferred relationship Some 1
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trastuzumab emtansine Inferred relationship Some 1

This concept is not in any reference sets

Back to Start